December 3 Biotech Update- CELG partnering and some interesting price action

The market sold off and took a number of biotechs with it, although there were some that bucked the trend. I would not read anything into the selling today as.

November 12- EOD

Well, I think it was more of the same in the sector writ large with the biggest news obviously being SRPT, which I will touch on below. I was surprised.

October 23-EOD

Not a lot of news in terms of data, although we saw BMY, AMGN, and LLY report earnings. The biotech sector was not as much of a relative underperformer today..

October 17- EOD

A mixed day in the market which was nice to see a day in which not all stocks were moving in the same direction. Obviously had some stock specific news.

October 16- EOD

With the approach of an end (as temporary as it is likely to be) of the stalemate in Washington you thought we would be approaching the end of the macro.

October 8- Mid Day

While I wanted some more news from the biotech sector this was not exactly what I was planning. I discuss my thoughts on ARIA in an article on the street,.

September 30-EOD

There was certainly some interesting news and action today. The market was weak early but biotech was much more mixed than one would have expected. It is good to see.

September 30-EOD

There was certainly some interesting news and action today. The market was weak early but biotech was much more mixed than one would have expected. It is good to see.

September 30-EOD

There was certainly some interesting news and action today. The market was weak early but biotech was much more mixed than one would have expected. It is good to see.

September 4- EOD

There was some nice action in biotech land today despite not being particularly busy in terms of news. There was some interesting stock specific action and the sector was a.

August 2- EOD

Fairly quiet day after a rather eventful week, so it is nice to have a little less to write about as we ease into the weekend. 1. I wanted to.

July 31- EOD

Well, it was certainly a news filled evening and it will take a couple of days to sort through it all, so today will be a first cut. In general.

July 19- EOD

Really seemed like a quiet summer day to end the week. Not much to talk about but a couple of follow up notes from earlier discussions. 1. To continue from.

July 15- EOD

Well, there was not a lot of news out there in biotech land but oddly there is a lot I want to talk about and will work through it over.

June 27- EOD

I thought today would be a much better day in the market for biotechs and they looked strong early but did not seem to have any real follow through. Not.

June 14- Midday

This is midday today as I will be out of my office for the rest of the day. So an early surprise. A very odd day today in the market..

May 24 – End Of Day Biotech Wrap-up

Really another slow day entering into the long weekend. From my perspective, there were really only two really interesting moves. 1. AVEO was a bit of a shocker. AVEO disclosed.

May 22 – End Of Day Biotech Wrap-up

While the market got some intraday whipsaw action, it seemed generally good and biotechs did well- early. We had a late day sell-off with biotechs seeming to do better than.

May 20th – End Of Day Biotech Wrap-up

Outside of a not completely unexpected merger, it was a relatively quite start to the week. As has been par for the course, ASCO oncology stocks tended to be weak.

Week’s Option Activity (5/13~5/17)

The following stocks had notable activity in their options during the past week: $OPTR (5/13): 2,250 SEP 17.50 strike Calls were sold against equal number of purchased JUN 12.5 Puts.